Literature DB >> 17100761

Antibody reactivity to heat shock protein 70 and inner ear-specific proteins in patients with idiopathic sensorineural hearing loss.

A E Tebo1, P Szankasi, T A Hillman, C M Litwin, H R Hill.   

Abstract

Deafness is attributable to autoimmunity in a subset of adult patients with sensorineural hearing loss (SNHL) of unknown aetiology. To determine the roles of self-antigens in the pathogenesis of idiopathic SNHL, we analysed antibody responses to the inner ear-specific proteins, cochlin and beta-tectorin as well as the non-specific heat shock protein 70 (HSP70). Recombinant cochlin and beta-tectorin proteins were used in a qualitative Western blot assay for the detection of antigen-specific IgG antibodies in 58 patients with idiopathic SNHL and 28 healthy blood donors. In the same study cohort, we also used a Western blot assay to assess IgG antibody responses to the recombinant human HSP70. Of the 58 patient samples analysed, 19 tested positive to the HSP70, eight to cochlin and one to beta-tectorin, giving a prevalence of 33, 14 and 2%, respectively. Only one patient sample was reactive for HSP70, cochlin and beta-tectorin, seven of the remaining eight cochlin IgG antibody-positive samples were monospecific. Thus, cochlin-specific antibodies were observed predominantly in HSP70 IgG-negative patients demonstrating an additive value for testing this antibody response in patients with idiopathic SNHL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17100761      PMCID: PMC1810414          DOI: 10.1111/j.1365-2249.2006.03227.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  COCH5B2 is a target antigen of anti-inner ear antibodies in autoimmune inner ear diseases.

Authors:  M R Boulassel; J P Tomasi; N Deggouj; M Gersdorff
Journal:  Otol Neurotol       Date:  2001-09       Impact factor: 2.311

2.  Identification of the protein product of the Coch gene (hereditary deafness gene) as the major component of bovine inner ear protein.

Authors:  T Ikezono; A Omori; S Ichinose; R Pawankar; A Watanabe; T Yagi
Journal:  Biochim Biophys Acta       Date:  2001-03-26

3.  Antibodies to inner ear antigens in Meniere's disease.

Authors:  L Riente; F Bongiorni; A Nacci; P Migliorini; G Segnini; A Delle Sedie; F Ursino; S Tommasi; B Fattori
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

4.  Myelin protein Po as a potential autoantigen in autoimmune inner ear disease.

Authors:  M Y Cao; V J Dupriez; M H Rider; N Deggouj; M C Gersdorff; G G Rousseau; J P Tomasi
Journal:  FASEB J       Date:  1996-12       Impact factor: 5.191

5.  Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease.

Authors:  José Ramón García Berrocal; Rafael Ramírez-Camacho; Beatriz Arellano; Juan Antonio Vargas
Journal:  Laryngoscope       Date:  2002-02       Impact factor: 3.325

6.  Inner ear autoantibodies in patients with sensorineural hearing loss.

Authors:  K Kosaka; S Yamanobe; S Tomiyama; T Yagi
Journal:  Acta Otolaryngol Suppl       Date:  1995

7.  Utility of laboratory testing in autoimmune inner ear disease.

Authors:  K Hirose; M H Wener; L G Duckert
Journal:  Laryngoscope       Date:  1999-11       Impact factor: 3.325

8.  Evidence linking the 68 kilodalton antigen identified in progressive sensorineural hearing loss patient sera with heat shock protein 70.

Authors:  P B Billings; E M Keithley; J P Harris
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-03       Impact factor: 1.547

9.  Guinea pig inner ear antigens: extraction and application to the study of human autoimmune inner ear disease.

Authors:  M Y Cao; N Deggouj; M Gersdorff; J P Tomasi
Journal:  Laryngoscope       Date:  1996-02       Impact factor: 3.325

10.  Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.

Authors:  Jeffrey P Harris; Michael H Weisman; Jennifer M Derebery; Mark A Espeland; Bruce J Gantz; A Julianna Gulya; Paul E Hammerschlag; Maureen Hannley; Gordon B Hughes; Richard Moscicki; Ralph A Nelson; John K Niparko; Steven D Rauch; Steven A Telian; Patrick E Brookhouser
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

View more
  7 in total

1.  Hearing and vestibular deficits in the Coch(-/-) null mouse model: comparison to the Coch(G88E/G88E) mouse and to DFNA9 hearing and balance disorder.

Authors:  Sherri M Jones; Nahid G Robertson; Shelly Given; Anne B S Giersch; M Charles Liberman; Cynthia C Morton
Journal:  Hear Res       Date:  2010-11-10       Impact factor: 3.208

2.  Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study.

Authors:  Georgios K Tsirves; Paraskevi V Voulgari; Eleftherios Pelechas; Asimakis D Asimakopoulos; Alexandros A Drosos
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-30       Impact factor: 2.503

3.  A novel COCH mutation associated with autosomal dominant nonsyndromic hearing loss disrupts the structural stability of the vWFA2 domain.

Authors:  Hyun-Ju Cho; Hong-Joon Park; Maria Trexler; Hanka Venselaar; Kyu Yup Lee; Nahid G Robertson; Jeong-In Baek; Beom Sik Kang; Cynthia C Morton; Gert Vriend; László Patthy; Un-Kyung Kim
Journal:  J Mol Med (Berl)       Date:  2012-05-19       Impact factor: 4.599

4.  A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction.

Authors:  Nahid G Robertson; Sherri M Jones; Theru A Sivakumaran; Anne B S Giersch; Sara A Jurado; Linda M Call; Constance E Miller; Stéphane F Maison; M Charles Liberman; Cynthia C Morton
Journal:  Hum Mol Genet       Date:  2008-08-12       Impact factor: 6.150

5.  Polymorphisms of CD16A and CD32 Fcγ receptors and circulating immune complexes in Ménière's disease: a case-control study.

Authors:  José A Lopez-Escamez; Pablo Saenz-Lopez; Irene Gazquez; Antonia Moreno; Carlos Gonzalez-Oller; Andrés Soto-Varela; Sofía Santos; Ismael Aran; Herminio Perez-Garrigues; Agueda Ibañez; Miguel A Lopez-Nevot
Journal:  BMC Med Genet       Date:  2011-01-05       Impact factor: 2.103

Review 6.  Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities.

Authors:  Chen Hu; Jing Yang; Ziping Qi; Hong Wu; Beilei Wang; Fengming Zou; Husheng Mei; Jing Liu; Wenchao Wang; Qingsong Liu
Journal:  MedComm (2020)       Date:  2022-08-02

Review 7.  Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss.

Authors:  Takayuki Okano
Journal:  Front Pharmacol       Date:  2014-09-02       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.